Detalhe da pesquisa
1.
Circulating Tumor DNA as a Predictive Biomarker for Clinical Outcomes With Margetuximab and Pembrolizumab in Pretreated HER2-Positive Gastric/ Gastroesophageal Adenocarcinoma.
Oncology (Williston Park)
; 37(4): 176-183, 2023 04 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-37104758
2.
Margetuximab plus pembrolizumab in patients with previously treated, HER2-positive gastro-oesophageal adenocarcinoma (CP-MGAH22-05): a single-arm, phase 1b-2 trial.
Lancet Oncol
; 21(8): 1066-1076, 2020 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-32653053
3.
Association of illness understanding with advance care planning and end-of-life care preferences for advanced cancer patients and their family members.
Support Care Cancer
; 28(6): 2959-2967, 2020 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-31768736
4.
The Attitudes of Physicians and the General Public toward Prognostic Disclosure of Different Serious Illnesses: a Korean Nationwide Study.
J Korean Med Sci
; 35(47): e401, 2020 Dec 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-33289368
5.
Erratum: Correction of the Text in the Article "Table": Discordance between Physician and the General Public Perceptions of Prognostic Disclosure to Children with Serious Illness: a Korean Nationwide Study.
J Korean Med Sci
; 35(6): e74, 2020 Feb 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-32056405
6.
Early risk stratification for diffuse large B-cell lymphoma integrating interim Deauville score and International Prognostic Index.
Ann Hematol
; 98(12): 2739-2748, 2019 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-31712879
7.
A phase I/II study of poziotinib combined with paclitaxel and trastuzumab in patients with HER2-positive advanced gastric cancer.
Gastric Cancer
; 22(6): 1206-1214, 2019 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-30945121
8.
Correction to: Priorities of a "good death" according to cancer patients, their family caregivers, physicians, and the general population: a nationwide survey.
Support Care Cancer
; 27(10): 3921-3926, 2019 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-31309297
9.
Erratum: Correction of Ethics Statement: Discordance between Physician and the General Public Perceptions of Prognostic Disclosure to Children with Serious Illness: a Korean Nationwide Study.
J Korean Med Sci
; 34(3): e30, 2019 Jan 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-30662391
10.
Efficacy and tolerability of ramucirumab monotherapy or in combination with paclitaxel in gastric cancer patients from the Expanded Access Program Cohort by the Korean Cancer Study Group (KCSG).
Gastric Cancer
; 21(5): 819-830, 2018 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-29427038
11.
Feasibility and accessibility of electronic patient-reported outcome measures using a smartphone during routine chemotherapy: a pilot study.
Support Care Cancer
; 26(11): 3721-3728, 2018 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-29732483
12.
Priorities of a "good death" according to cancer patients, their family caregivers, physicians, and the general population: a nationwide survey.
Support Care Cancer
; 26(10): 3479-3488, 2018 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-29682690
13.
Discordance between Physician and the General Public Perceptions of Prognostic Disclosure to Children with Serious Illness: a Korean Nationwide Study.
J Korean Med Sci
; 33(49): e327, 2018 Dec 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-30505258
14.
Efficacy and Safety of FOLFIRI Regimen in Elderly Versus Nonelderly Patients with Metastatic Colorectal or Gastric Cancer.
Oncologist
; 22(3): 293-303, 2017 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-28209749
15.
A NOTCH1 gene copy number gain is a prognostic indicator of worse survival and a predictive biomarker to a Notch1 targeting antibody in colorectal cancer.
Int J Cancer
; 138(1): 195-205, 2016 Jan 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-26152787
16.
Long-Term Outcomes after Imatinib Mesylate Discontinuation in Chronic Myeloid Leukemia Patients with Undetectable Minimal Residual Disease.
Acta Haematol
; 135(3): 133-9, 2016.
Artigo
em Inglês
| MEDLINE | ID: mdl-26535871
17.
Potent antitumor activity of cabozantinib, a c-MET and VEGFR2 inhibitor, in a colorectal cancer patient-derived tumor explant model.
Int J Cancer
; 136(8): 1967-75, 2015 Apr 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-25242168
18.
Ramosetron Versus Ondansetron in Combination With Aprepitant and Dexamethasone for the Prevention of Highly Emetogenic Chemotherapy-Induced Nausea and Vomiting: A Multicenter, Randomized Phase III Trial, KCSG PC10-21.
Oncologist
; 20(12): 1440-7, 2015 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-26512046
19.
Glutamine protects mice from acute graft-versus-host disease (aGVHD).
Biochem Biophys Res Commun
; 435(1): 94-9, 2013 May 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-23624505
20.
Lymphocyte-mediated macrophage apoptosis during IL-12 stimulation.
Cytokine
; 64(1): 62-70, 2013 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-23953854